Posts

Liver-targeting drug reverses obesity, lowers cholester...

A University of Massachusetts Amherst biomedical engineer has used a nanogel-bas...

Using neuroscience to stop phantom braking

EAST LANSING, Mich. — Recently, when customers began complaining that their vehi...

Gestational weight gain increased in Louisiana during t...

Louisiana women who gave birth during the COVID-19 pandemic were 3 to 7 percent ...

Surpassing the human eye: machine learning image analys...

Machine learning model provides quick method for determining the composition of ...

Boosting neuroscience training to help children flourish

Professionals working with children and young people will be offered training in...

Vision for future micro-optical technology based on met...

Metasurfaces, also known as invisibility cloak technology, are an artificial mat...

Monoblock Mastery: Capmatic's Innovative Approach to In...

Explore the revolutionary Monoblock systems by Capmatic, where innovation meets ...

BR-6002 by Boryung Pharmaceutical for Cardiovascular Di...

BR-6002 is under clinical development by Boryung Pharmaceutical and currently in...

BR-6002 by Boryung Pharmaceutical for Gastric Ulcers: L...

BR-6002 is under clinical development by Boryung Pharmaceutical and currently in...

BR-6002 by Boryung Pharmaceutical for Duodenal Ulcer: L...

BR-6002 is under clinical development by Boryung Pharmaceutical and currently in...

Signal: Allina health will no longer bar indebted patie...

Following public outcry and a government investigation, Allina Health has renege...

Lutetium (lu177) lilotomab satetraxetan by Thor Medical...

Lutetium (lu177) lilotomab satetraxetan is under clinical development by Thor Me...

Specialised Therapeutics partners with Treeway to licen...

Specialised Therapeutics has entered into a licensing agreement with Treeway for...

Phebra, University of Wollongong partner to develop can...

Pharmaceutical firm Phebra has reached a new six-year collaboration agreement wi...

Sandoz concludes acquisition of Mycamine antifungal age...

Novartis division Sandoz has concluded the acquisition of global brand rights fo...

Janssen submits sBLA to FDA for NSCLC combination therapy

The Janssen has submitted a sBLA to the US FDA for RYBREVANT plus chemotherapy f...